RAiD 10.26259/ae1d0c82 Hybrid Catheter Ablation and Surgical Ablation as a ‘Bail Out’ Strategy In Patients with Atrial Fibrillation Resistant To Catheter Ablation
Dates
Start Date
01-May-2024
End Date
01-Jul-2024
Titles
Title
Hybrid Catheter Ablation and Surgical Ablation as a ‘Bail Out’ Strategy In Patients with Atrial Fibrillation Resistant To Catheter Ablation
Title Type
Primary
Title Type: Primary Preferred full description or abstract.
Start Date
01-Mar-2024
End Date
01-Jul-2024
Language
English
Descriptions
Description
Description textAtrial fibrillation (AF) is the most common arrythmia increasing the risk of stroke and limiting one’s ability to carry out day to day activities. Catheter ablation uses various forms of energy to ablate aberrant parts of the left atrium, thus restoring a normal rhythm. While this treatment is effective for patients with short-lasting AF, paroxysmal atrial fibrillation (PAF), the outcomes for patients with longer standing AF, persistent AF (PsAF) and long-standing persistent AF (LSPAF), are suboptimal. The Hybrid Catheter Ablation and Surgical Ablation (HyCASA) procedure was developed to treat patients with difficult-to-treat AF. It combines catheter ablation of the endocardium, performed by a cardiologist, with surgical ablation of the epicardium, performed by a cardiothoracic surgeon, in either a staged or concurrent approach. This procedure has the advantage of creating a durable lesion of the posterior left atrium while minimizing the risk of damage to local structures, such as the oesophagus. This procedure has been shown to be more effective than catheter ablation alone for PsAF and LsPAF, with acceptable safety.
Our primary aim is to investigate the efficacy of the HyCASA procedure in patients with AF who have previously failed at least one catheter ablation and anti-arrythmic drugs. Procedural efficacy will be demonstrated by the proportion of patients who fail the procedure over at least 12 months of follow up time. We will also demonstrate efficacy using AF burden over 12 months, where AF burden is the time spent in AF divided by the total monitoring time.
This is important research to conduct because it provides evidence as to whether the HyCASA procedure is a viable option for patients with AF who failed catheter ablation and anti-arrythmic drugs previously.
Description Type
Primary
Description Type: Primary Preferred full description or abstract
Language
English
Contributors
Contributor
https://orcid.org/0000-0003-4492-1103
Leader
Yes
Contact
Yes
Positions
Position
Principal or Chief Investigator
Position: Principal or Chief Investigator Principal investigator refers to the person(s) in charge of a research project
Start Date
01-Mar-2024
End Date
01-Jul-2024
Roles
Conceptualization
Organisations
No Entries
RelatedObjects
No Entries
Alternate Identifier
No Entries
Alternate URLs
No Entries
Related RAiDs
No Entries
Access
Type
Open Access
Type: Open Access Open access refers to a resource that is immediately and permanently online, and free for all on the Web, without financial and technical barriers.The resource is either stored in the repository or referenced to an external journal or trustworthy archive.
Language
eng
Text
Open
Embargo Expiry
2025-05-01
Subjects
No Entries
Raw Data
{ "metadata": { "created": 1714542512, "updated": 1742955867 }, "identifier": { "id": "http://raid.local/10.26259/ae1d0c82", "schemaUri": "https://raid.org/", "registrationAgency": { "id": "https://ror.org/038sjwq14", "schemaUri": "https://ror.org/" }, "owner": { "id": "https://ror.org/02stey378", "schemaUri": "https://ror.org/", "servicePoint": 20000003 }, "raidAgencyUrl": "http://localhost:808010.26259/ae1d0c82", "license": "Creative Commons CC-0", "version": 4 }, "title": [ { "text": "Hybrid Catheter Ablation and Surgical Ablation as a ‘Bail Out’ Strategy In Patients with Atrial Fibrillation Resistant To Catheter Ablation", "type": { "id": "https://vocabulary.raid.org/title.type.schema/5", "schemaUri": "https://vocabulary.raid.org/title.type.schema/376" }, "startDate": "2024-03-01", "endDate": "2024-07-01", "language": { "id": "eng", "schemaUri": "https://www.iso.org/standard/74575.html" } } ], "date": { "startDate": "2024-05-01", "endDate": "2024-07-01" }, "description": [ { "text": "Description textAtrial fibrillation (AF) is the most common arrythmia increasing the risk of stroke and limiting one’s ability to carry out day to day activities. Catheter ablation uses various forms of energy to ablate aberrant parts of the left atrium, thus restoring a normal rhythm. While this treatment is effective for patients with short-lasting AF, paroxysmal atrial fibrillation (PAF), the outcomes for patients with longer standing AF, persistent AF (PsAF) and long-standing persistent AF (LSPAF), are suboptimal. The Hybrid Catheter Ablation and Surgical Ablation (HyCASA) procedure was developed to treat patients with difficult-to-treat AF. It combines catheter ablation of the endocardium, performed by a cardiologist, with surgical ablation of the epicardium, performed by a cardiothoracic surgeon, in either a staged or concurrent approach. This procedure has the advantage of creating a durable lesion of the posterior left atrium while minimizing the risk of damage to local structures, such as the oesophagus. This procedure has been shown to be more effective than catheter ablation alone for PsAF and LsPAF, with acceptable safety. \nOur primary aim is to investigate the efficacy of the HyCASA procedure in patients with AF who have previously failed at least one catheter ablation and anti-arrythmic drugs. Procedural efficacy will be demonstrated by the proportion of patients who fail the procedure over at least 12 months of follow up time. We will also demonstrate efficacy using AF burden over 12 months, where AF burden is the time spent in AF divided by the total monitoring time. \nThis is important research to conduct because it provides evidence as to whether the HyCASA procedure is a viable option for patients with AF who failed catheter ablation and anti-arrythmic drugs previously.", "type": { "id": "https://vocabulary.raid.org/description.type.schema/318", "schemaUri": "https://vocabulary.raid.org/description.type.schema/320" }, "language": { "id": "eng", "schemaUri": "https://www.iso.org/standard/74575.html" } } ], "access": { "type": { "id": "https://vocabularies.coar-repositories.org/access_rights/c_abf2/", "schemaUri": "https://vocabularies.coar-repositories.org/access_rights/" }, "statement": { "text": "Open", "language": { "id": "eng", "schemaUri": "https://www.iso.org/standard/74575.html" } }, "embargoExpiry": "2025-05-01" }, "alternateUrl": [], "contributor": [ { "id": "https://orcid.org/0000-0003-4492-1103", "schemaUri": "https://orcid.org/", "status": "UNAUTHENTICATED", "uuid": "bce87ea4-b4eb-4c1b-aa08-fb7c02d682a7", "position": [ { "schemaUri": "https://vocabulary.raid.org/contributor.position.schema/305", "id": "https://vocabulary.raid.org/contributor.position.schema/307", "startDate": "2024-03-01", "endDate": "2024-07-01" } ], "role": [ { "schemaUri": "https://credit.niso.org/", "id": "https://credit.niso.org/contributor-roles/conceptualization/" } ], "leader": true, "contact": true } ], "organisation": [], "subject": [], "relatedRaid": [], "relatedObject": [], "alternateIdentifier": [], "spatialCoverage": [] }